Internal Server Error

About Anzu Partners

Anzu Partners is a venture capital firm founded in 2014. It is primarily based out of Washington, DC, United States. As of Dec 2025, Anzu Partners has invested in 46 companies. It primarily invests in Series A round in United States based startups. Its investments are spread across a wide range of sectors from High Tech to Enterprise Applications and Life Sciences. Most recently it participated in the $***** Series B round of South 8 Overall, Anzu Partners portfolio has seen 3 IPOs and 5 acquisitions including key companies like Arduino, Ai-Media and Pike13. A lot of funds co-invest with Anzu Partners, with names like Genoa Ventures sharing a substantial percentage of its portfolio. Anzu Partners has team of 18 people including 7 partners.
Key Metrics
Portfolio Count
Portfolio Locations
Rounds of Entry
Series A, Series B & 4 more
Portfolio IPOs
Portfolio Acquisitions
Portfolio Soonicorns
Deals in last 12 months

Anzu Partners' List of Top Investments

Anzu Partners has a portfolio of 46 companies. Their most notable investments are in TeraPore and Opscura.Their portfolio spans across United States, Canada, Australia and 3 more locations. They have invested in High Tech, Enterprise Applications, Life Sciences and 14 other sectors, across stages such as Series A, Series B  and 4 more. Here is the list of top investments by Anzu Partners:

1. 6K

Provider of nanotechnology-based metal powders. It develops microwave-based plasma technology to develop nano metal powders. It has applications in additive manufacturing, batteries, lighting and display materials, semiconductor CMP, federal and defense specialties, ceramics, advanced coatings, and nano-engineered powders.

Key facts about 6K

immunoSCAPE offers specialized services for biomarker and target identification through its unique high-dimensional immune profiling platform. Founded as a spin-off from the lab of Dr Evan Newell at Singapore Immunology Network, A*STAR, the company uses its expertise in immunology and mass cytometry to measure alterations of immune cells and T-cell specificity in specific and helps in optimizing the early phase R&D pipeline for oncology and infectious diseases.Their proprietary technology leverages the power of mass cytometry (Cytometry by Time of Flight), T-Cell antigen discovery and cell profiling techniques and related data analysis tools. Their services for immunotherapy development include surrogate marker ID, disease status and progression determination and prediction, discovery of novel targets and biomarkers, and efficacy assessment in preclinical and clinical stages.

Key facts about ImmunoSCAPE

  • Founded Year: 2016
  • Location: Singapore (Singapore)
  • Stage: Series B
  • Total Funding till date: $39M
  • Employee Count: 22 as on Jul 31, 2026
  • Investors: EDBI, Amgen and 16 Others
  • Latest Funding Round: Series B, Sep 20, 2022, $*****
  • Highlight: Editors' Pick
Provider of an open-source electronics prototyping platform. Its software and the hardware-based platform are designed for providing a solution for hobbyists, students, and professionals to create devices that interact with their environment using sensors and actuators.

Key facts about Arduino

Developer of hardware and software for edge-to-cloud artificial intelligence compute. The company provides hardware and software designed for orchestration between on-device and cloud deployments. It offers chiplets, ASICs, and standard form-factor PCIe cards. The company's technology integrates into diverse form factors, enabling artificial intelligence capabilities in partner and customer solutions.

Key facts about EnCharge

NanoCellect Biomedical is a developer of molecular diagnostics, and improve personalized medicine. The company offers WOLF Cell Sorter, which uses a closed fluid-path microfluidic cartridge that enables cell sorting, and avoids biohazard and shear stress issues associated with traditional cell sorters. It claims that this technology sorts cells at the highest purity with almost no loss of viability. This technology has downstream applications of gene expression and sequencing. It also used in sorting rare cells such as circulating tumor cells (CTCs) from blood samples.

Key facts about NanoCellect Biomedical

Anzu Partners' Investments by Stage

Anzu Partners is primarily an Early Stage Investor investor majorly investing in Series A (22) rounds where average round size is $289M, Series B (9) rounds where average round size is $160M and Seed (6) rounds where average round size is $23.9M.
Here are Anzu Partners' investments by stage:
Stage of entry
No. of Investments
Series A
22
Series B
9
Seed
6
Post IPO
1
Series D
1
Others
1
Breakdown of Anzu Partners' investments by stage of entrySeries A (22)Series B (9)
Note: We have considered here, only first round of investments

Anzu Partners' Investments by Sector

Anzu Partners has a diverse portfolio, with companies operating in the High Tech, Life Sciences, Enterprise Applications, Energy Tech and Semiconductors. Notably, it has invested in 42 Enterprise (B2B) companies, 37 Tech companies, 16 Tech hardware companies and at least 14 companies focusing on Software.
Here are Anzu Partners' investments by sector:
Sector
No. of Investments
High Tech
18
Life Sciences
12
Enterprise Applications
9
Energy Tech
7
Semiconductors
7
Others
35
Breakdown of Anzu Partners' investments by sectorsHigh Tech (18)Life Sciences (12)
Note: We have considered here, only first round of investments

Anzu Partners' Investments by Geography

Anzu Partners has made most investments in United States (35), followed by Canada where it has made 2 investments.
Here are Anzu Partners' investments by geography:
Country
No. of Investments
United States
35
Canada
2
Austria
1
Singapore
1
Sweden
1
Breakdown of Anzu Partners' investments by countriesUnited States (35)Canada (2)
Note: We have considered here, only first round of investments

Anzu Partners' recent investments

Anzu Partners has not made any investment in 2026 so far.
Here are the most recent investments by Anzu Partners:
Date
Company
Location
Round Details
Round Amount
Co-Investors
Dec 09, 2025
United States
Series B
8029
Feb 13, 2025
United States
Series B
1548
Sep 20, 2024
Austria
Series A
4560
Jul 19, 2024
United States
Series E
7367
Jun 27, 2024
Canada
Series A
8076

IPOs and Publicly Listed companies in Anzu Partners' Portfolio

3 of Anzu Partners' portfolio companies have become public. NUBURU got listed on the American Stock Exchange (NYSEAMERICAN), in Oct 2020 and Ai-Media got listed on the Australian Securities Exchange (ASX) at marketcap of $129M.
Here are Anzu Partners' portfolio companies that went public:
Company
IPO Date
First Invested on
First Round of Investment
Round Size
Oct 23, 2020
Dec 03, 2020
Post IPO
8050
Sep 15, 2020
-
-
9539
Apr 20, 2018
Oct 2016
Series D
9479

Acquired companies in Anzu Partners' Portfolio

5 companies from Anzu Partners' portfolio have been acquired. The most recent acquisition was Arduino in Oct 2025 by Qualcomm for $*****.
Here are Anzu Partners' portfolio companies that got acquired most recently:
Company
Acquisition Date
First Invested on
First Round of Investment
Round Size
Oct 07, 2025
Jun 08, 2022
Series B
4856
Nov 25, 2019
Jul 26, 2017
Seed
8332
Jan 09, 2018
Dec 20, 2016
Series A
4455
Jan 04, 2017
May 04, 2016
Series A
8521
Mar 22, 2016
Jan 2016
Unattributed
1133

Team profile of Anzu Partners

Anzu Partners has a team of 18 members including 7 Partners, 1 Venture Partner and 5 Principals located in United States. Anzu Partners' team sits on the board of 2 companies.
Here is a list of top team members in Anzu Partners:
Name
Designation
Location
Board Memberships
Contact Details
Partner
St. Petersburg
Partner
San Diego
Partner
Philadelphia
-
Partner
-
-
-
Partner
Naples
-
-
Partner
Washington, DC
-
-
Partner
United States
-
Venture Partner
Washington, DC
-
-
Principal
Boston
-
-
Principal
Cambridge
-

Co-investors of Anzu Partners

Over the past 11 years, 245 investors have co-invested in Anzu Partners's portfolio companies. This includes funds and angels.

  • Invested before Anzu PartnersOSTI, HHS and 72 others have invested in rounds before Anzu Partners. There are 3 companies where OSTI has invested before Anzu Partners and 3 companies where HHS has invested before Anzu Partners.
  • Top Co-investors of Anzu Partners66 investors entered a company along with Anzu Partners. These include investors like Genoa Ventures (2 companies).
  • Invested after Anzu PartnersA total of 105 investors have invested in Anzu Partners's portfolio after their investments. Top Investors include DOE (2 companies), Lockheed Martin (2 companies) and Porsche Ventures (2 companies).

Recent News related to Anzu Partners

View all news related to Anzu Partners

FAQs about Anzu Partners

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford